Results 131 to 140 of about 22,509 (201)

Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date. [PDF]

open access: yesFront Endocrinol (Lausanne)
Van der Borght E   +8 more
europepmc   +1 more source

The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype specific. [PDF]

open access: yesJCI Insight
Sewerin S   +31 more
europepmc   +1 more source

Genotype-phenotype heterogeneity among patients with lipodystrophy harboring rare POLD1 variants.

open access: yesJ Clin Endocrinol Metab
Hoff FW   +5 more
europepmc   +1 more source

Lipodystrophy: an uncommon cause of insulin resistance and young-onset diabetes. [PDF]

open access: yesJCEM Case Rep
Chaturvedi R   +5 more
europepmc   +1 more source

DICER-driven regulation of lipid metabolism and macrophage-adipocyte crosstalk in partial lipodystrophy. [PDF]

open access: yesBiomed Pharmacother
Rocha AL   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy